Drug Development Meetings
Join FDAnews Feb. 24 to learn about "Drug Marketing Practices in Europe: Navigating Tough Rules and New Enforcement," a 90-minute audioconference. Hear former FDA official Linda Horton, now an attorney with Hogan & Hartson, explain how the new EU Community Code on Medicinal Products affects your marketing activities, including your relationship with health professionals. On Feb. 25, receive a concise and expert analysis of the "Medicare Part D for Drugmakers: New Requirements, New Risks, New Markets," presented in a 90-minute audioconference by Keith Korenchuk of McGuireWoods and Sheryl Vacca of Deloitte & Touche.
Feb. 23: cGMP Predicate Rules
What FDA Expects From Your Computer Systems
Part 2 of a 2-Part Series
An audioconference
Your Office
(703) 538-7600
FDAnews
www.fdanews.com/wbi/conferences/gmprules2.html (http://www.fdanews.com/wbi/conferences/gmprules2.html)
Feb. 24: Drug Marketing Practices in Europe
Navigating Tough Rules and New Enforcement
An audioconference
Your Office
(703) 538-7600
FDAnews
www.fdanews.com/wbi/conferences/eurules.html (http://www.fdanews.com/wbi/conferences/eurules.html)
Feb. 24-25: Auditing Clinical Trials for GCP Compliance
New Brunswick, N.J.
(212) 661-3500 x3091
PTi international
jmcconnell@pti-international.com
www.pti-international.com
Feb. 24-25: Project Management for Clinical Trials
San Francisco, Calif.
(212) 661-3500
PTi international
jmcconnell@pti-international.com
www.pti-international.com
Feb. 25: Medicare Part D for Drugmakers
New Requirements, New Risks, New Markets
An audioconference
Your Office
(703) 538-7600
FDAnews
www.fdanews.com/wbi/conferences/medicarepartd.html (http://www.fdanews.com/wbi/conferences/medicarepartd.html)
Feb. 28: Preparing for Systems-Based Inspections
An audioconference with Martin Browning
Your Office
(703) 538-7600
FDAnews
www.fdanews.com/wbi/conferences/inspections.html (http://www.fdanews.com/wbi/conferences/inspections.html)
Feb. 28-March 1: Implementing the Common Technical Document Format for NDA/BLA Submissions
Washington, D.C.
(212) 661-3500 x3091
PTi international
jmcconnell@pti-international.com
www.pti-international.com
Feb. 28-March 1: Third International Protein Phosphorylation Drug Discovery World Summit
La Jolla, Calif.
(646) 336-7030
Strategic Research Institute
sgrodsky@srinstitute.com
www.srinstitute.com
March 2-3: Project Management in Drug Development: Discovery and Preclinical
Philadelphia, Pa.
(212) 661-3500
PTi international
jmcconnell@pti-international.com
www.pti-international.com
March 2-4: INDs and NDAs and FDA Regulations
Amsterdam, Netherlands
(732) 238-1600
The Center for Professional Advancement
info@cfpa.com
www.cfpa.com
March 4: The Impact of the EU Clinical Trials Directive on the Clinical Supply Chain and Clinical Manufacturing Facilities
Rome, Italy
(301) 656-5900
PDA
tri@pda.org
www.pda.org
March 4: cGMP and Other Regulatory Compliance During Development of Biopharmaceuticals and Biologics
Malvern, Pa.
(610) 688-1708
The Center for Professional Innovation & Education
info@cfpie.com
www.cfpie.com